{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:48:09Z","timestamp":1792082889691,"version":"4.4.0"},"reference-count":75,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T00:00:00Z","timestamp":1599609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2020.00960","type":"journal-article","created":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T04:19:39Z","timestamp":1599625179000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":40,"title":["The Expanding Clinical Spectrum of Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Associated Disease in Children and Adults"],"prefix":"10.3389","volume":"11","author":[{"given":"Erica","family":"Parrotta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilya","family":"Kister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,9,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/0896-8411(89)90149-2","article-title":"Chronic experimental autoimmune encephalomyelitis in the guinea pig. presence of anti-M2 antibodies in central nervous system tissue and the possible role of M2 autoantigen in the induction of the disease","volume":"2","author":"Lebar","year":"1989","journal-title":"J Autoimmunity"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1212\/WNL.0b013e31826aac4e","article-title":"Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype","volume":"79","author":"Kitley","year":"2012","journal-title":"Neurology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/1742-2094-8-184","article-title":"Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders","volume":"8","author":"Mader","year":"2011","journal-title":"J Neuroinflamm"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1177\/1352458512470310","article-title":"Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica","volume":"19","author":"Rostasy","year":"2013","journal-title":"Mult Sclero J"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1007\/s00415-017-8596-7","article-title":"What proportion of AQP4-IgG-negative NMO spectrum disorder patients are MOG-IgG positive? A cross sectional study of 132 patients","volume":"264","author":"Hamid","year":"2017","journal-title":"J Neurol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3389\/fneur.2018.00217","article-title":"MOG-IgG-associated optic neuritis, encephalitis, and myelitis: lessons learned from neuromyelitis optica spectrum disorder","volume":"9","author":"Dos Passos","year":"2018","journal-title":"Front Neurol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.ophtha.2019.01.016","article-title":"Evidence of m\u00fcller glial dysfunction in patients with aquaporin-4 immunoglobulin g-positive neuromyelitis optica spectrum disorder","volume":"126","author":"You","year":"2019","journal-title":"Ophthalmology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/bpa.12099","article-title":"The pathology of an autoimmune astrocytopathy: lessons learned from neuromyelitis optica","volume":"24","author":"Lucchinetti","year":"2014","journal-title":"Brain Pathol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.1759-1961.2012.00030.x","article-title":"Neuromyelitis optica should be classified as an astrocytopathic disease rather than a demyelinating disease","volume":"3","author":"Fujihara","year":"2012","journal-title":"Clin Experimental Neuroimmunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e62","DOI":"10.1212\/NXI.0000000000000062","article-title":"Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder?","volume":"2","author":"Zamvil","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B11","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1093\/brain\/awx276","article-title":"Clinical presentation and prognosis in MOG-antibody disease: a UK study","volume":"140","author":"Jurynczyk","year":"2017","journal-title":"Brain"},{"key":"B12","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1177\/1352458519845112","article-title":"The clinical spectrum and incidence of anti-MOG-associated acquired demyelinating syndromes in children and adults","volume":"26","author":"de Mol","year":"2020","journal-title":"Mult Scler."},{"key":"B13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ajo.2018.07.020","article-title":"Myelin oligodendrocyte glycoprotein antibody\u2013positive optic neuritis: clinical characteristics, radiologic clues, and outcome","volume":"195","author":"Chen","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.pediatrneurol.2018.03.003","article-title":"Clinical characteristics of pediatric optic neuritis with myelin oligodendrocyte glycoprotein seropositive: a cohort study","volume":"83","author":"Chen","year":"2018","journal-title":"Pediatric Neurol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1007\/s00415-017-8583-z","article-title":"MOG antibody-related disorders: common features and uncommon presentations","volume":"264","author":"Cobo-Calvo","year":"2017","journal-title":"J Neurol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1212\/WNL.0000000000004312","article-title":"Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome","volume":"89","author":"Hennes","year":"2017","journal-title":"Neurology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1001\/jamaneurol.2019.2940","article-title":"Serial anti\u2013myelin oligodendrocyte glycoprotein antibody analyses and outcomes in children with demyelinating syndromes","volume":"77","author":"Waters","year":"2019","journal-title":"JAMA Neurol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12974-016-0718-0","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome","volume":"13","author":"Jarius","year":"2016","journal-title":"J Neuroinflamm"},{"key":"B19","doi-asserted-by":"publisher","first-page":"699","DOI":"10.2169\/internalmedicine.55.5727","article-title":"An adult case of anti-myelin oligodendrocyte glycoprotein (MOG) antibody-associated multiphasic acute disseminated encephalomyelitis at 33-year intervals","volume":"55","author":"Numa","year":"2016","journal-title":"Internal Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e1858","DOI":"10.1212\/WNL.0000000000005560","article-title":"Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: the MOGADOR study","volume":"90","author":"Cobo-Calvo","year":"2018","journal-title":"Neurology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1177\/1352458515593406","article-title":"Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis","volume":"22","author":"Ramanathan","year":"2016","journal-title":"Mult Sclero J"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.1212\/NXI.0000000000000040","article-title":"Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis","volume":"1","author":"Ramanathan","year":"2014","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B23","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1097\/ICU.0000000000000607","article-title":"Update on Pediatric Optic Neuritis","volume":"30","author":"Lock","year":"2019","journal-title":"Curr Opinion Ophthalmol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1136\/bjophthalmol-2017-311177","article-title":"Clinical features of demyelinating optic neuritis with seropositive myelin oligodendrocyte glycoprotein antibody in Chinese patients","volume":"102","author":"Zhao","year":"2018","journal-title":"British J Ophthalmol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1136\/bjophthalmol-2018-312399","article-title":"Clinical characteristics and prognosis of myelin oligodendrocyte glycoprotein antibody-seropositive paediatric optic neuritis in China","volume":"103","author":"Song","year":"2019","journal-title":"British J Ophthalmol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12974-018-1144-2","article-title":"MOG encephalomyelitis: international recommendations on diagnosis and antibody testing","volume":"15","author":"Jarius","year":"2018","journal-title":"J Neuroinflammation"},{"key":"B27","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1136\/jnnp-2017-316880","article-title":"Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination","volume":"89","author":"Ramanathan","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B28","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.msard.2018.10.003","article-title":"Atypical Anti-MOG syndrome with aseptic meningoencephalitis and pseudotumor cerebri-like presentations","volume":"27","author":"Narayan","year":"2019","journal-title":"Mult Sclero Relat Disorde"},{"key":"B29","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/WCO.0000000000000766","article-title":"Clinical phenotype, radiological features, and treatment of myelin oligodendrocyte glycoprotein-immunoglobulin G (MOG-IgG) optic neuritis","volume":"33","author":"Chen","year":"2020","journal-title":"Curr Opin Neurol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3109\/01658107.2015.1084332","article-title":"Anti-MOG (Myelin Oligodendrocyte Glycoprotein)\u2013positive severe optic neuritis with optic disc ischaemia and macular star","volume":"39","author":"Moura","year":"2015","journal-title":"Neuro-Ophthalmology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1007\/s00415-017-8615-8","article-title":"Optic neuritis in patients with anti-MOG antibodies spectrum disorder: MRI and clinical features from a large multicentric cohort in France","volume":"264","author":"Biotti","year":"2017","journal-title":"J Neurol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/brain\/awg045","article-title":"Chronic relapsing inflammatory optic neuropathy (CRION)","volume":"126","author":"Kidd","year":"2003","journal-title":"Brain"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1136\/jnnp-2019-320493","article-title":"Aquaporin-4 and myelin oligodendrocyte glycoprotein antibodies in immune-mediated optic neuritis at long-term follow-up","volume":"90","author":"Petzold","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B34","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/s12974-018-1335-x","article-title":"Chronic relapsing inflammatory optic neuropathy (CRION): a manifestation of myelin oligodendrocyte glycoprotein antibodies","volume":"15","author":"Lee","year":"2018","journal-title":"J Neuroinflamm"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1001\/archopht.119.9.1299","article-title":"Optic perineuritis: clinical and radiographic features","volume":"119","author":"Purvin","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jneuroim.2017.01.007","article-title":"MOG-antibody associated demyelinating disease of the CNS: a clinical and pathological study in Chinese Han patients","volume":"305","author":"Zhou","year":"","journal-title":"J Neuroimmunol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1136\/jnnp-2014-310206","article-title":"MRI and retinal abnormalities in isolated optic neuritis with myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies: a comparative study","volume":"87","author":"Akaishi","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1111\/ene.13932","article-title":"Uveitis and optic perineuritis in the context of myelin oligodendrocyte glycoprotein antibody seropositivity","volume":"26","author":"Ramanathan","year":"2019","journal-title":"Eur J Neurol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"101444","DOI":"10.1016\/j.msard.2019.101444","article-title":"Optic perineuritis with anti-myelin oligodendrocyte glycoprotein antibody","volume":"38","author":"Yanagidaira","year":"2020","journal-title":"Mult Sclero Relat Disorde"},{"key":"B40","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1001\/jamaneurol.2018.4053","article-title":"Clinical, radiologic, and prognostic features of myelitis associated with myelin oligodendrocyte glycoprotein autoantibody","volume":"76","author":"Dubey","year":"2019","journal-title":"JAMA Neurol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.msard.2019.02.016","article-title":"Isolated recurrent myelitis in a persistent MOG positive patient","volume":"30","author":"Anis","year":"2019","journal-title":"Mult Sclero Relat Disorde"},{"key":"B42","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.msard.2019.01.021","article-title":"Radiological characteristics of myelin oligodendrocyte glycoprotein antibody disease","volume":"29","author":"Salama","year":"2019","journal-title":"Mult Sclero Relat Disorde"},{"key":"B43","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1177\/1352458519840747","article-title":"Relapsing lumbosacral myeloradiculitis: an unusual presentation of mog antibody disease","volume":"26","author":"Sundaram","year":"2019","journal-title":"Mult Sclero J"},{"key":"B44","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.neurad.2019.06.001","article-title":"MRI features of demyelinating disease associated with anti-MOG antibodies in adults","volume":"46","author":"Den\u00e8ve","year":"2019","journal-title":"J Neuroradiol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.pediatrneurol.2018.06.003","article-title":"Anti-myelin oligodendrocyte glycoprotein antibody associated with gray matter predominant transverse myelitis mimicking acute flaccid myelitis: a presentation of two cases","volume":"86","author":"Wang","year":"2018","journal-title":"Pediatric Neurol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1212\/WNL.0b013e318228c0b1","article-title":"Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis","volume":"77","author":"Pr\u00f6bstel","year":"2011","journal-title":"Neurology"},{"key":"B47","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.clim.2010.11.013","article-title":"Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases","volume":"138","author":"Di Pauli","year":"2011","journal-title":"Clin Immunol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1136\/jnnp-2014-308346","article-title":"Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein","volume":"86","author":"Baumann","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B49","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1212\/WNL.0000000000004117","article-title":"Diagnostic algorithm for relapsing acquired demyelinating syndromes in children","volume":"89","author":"Hacohen","year":"2017","journal-title":"Neurology"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e731","DOI":"10.1212\/NXI.0000000000000731","article-title":"Clinical and imaging features of children with autoimmune encephalitis and MOG antibodies","volume":"7","author":"Wegener-Panzer","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1177\/1352458516631038","article-title":"Children with multiphasic disseminated encephalomyelitis and antibodies to the myelin oligodendrocyte glycoprotein (MOG): extending the spectrum of MOG antibody positive diseases","volume":"22","author":"Baumann","year":"2016","journal-title":"Mult Sclero J"},{"key":"B52","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.jns.2018.01.042","article-title":"Anti-myelin oligodendrocyte glycoprotein (MOG) antibodies in patients with optic neuritis and seizures","volume":"387","author":"Gutman","year":"2018","journal-title":"J Neurol Sci"},{"key":"B53","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1177\/1352458512466317","article-title":"Acute disseminated encephalomyelitis followed by recurrent or monophasic optic neuritis in pediatric patients","volume":"19","author":"Huppke","year":"2013","journal-title":"Mult Sclero J"},{"key":"B54","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S1474-4422(19)30488-0","article-title":"Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study","volume":"19","author":"Armangue","year":"2020","journal-title":"Lancet Neurol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"101500","DOI":"10.1016\/j.msard.2019.101500","article-title":"Anti-myelin oligodendrocyte glycoprotein antibody-positive acute disseminated encephalomyelitis mimicking limbic encephalitis: a case report","volume":"38","author":"Uchigami","year":"2020","journal-title":"Mult Scler Relat Disord."},{"key":"B56","doi-asserted-by":"publisher","first-page":"e322","DOI":"10.1212\/NXI.0000000000000322","article-title":"MOG antibody\u2013positive, benign, unilateral, cerebral cortical encephalitis with epilepsy","volume":"4","author":"Ogawa","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B57","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1007\/s00415-019-09440-8","article-title":"Unilateral cortical FLAIR-hyperintense lesions in anti-MOG-associated encephalitis with seizures (FLAMES): characterization of a distinct clinico-radiographic syndrome","volume":"266","author":"Budhram","year":"2019","journal-title":"J Neurol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jns.2018.06.028","article-title":"The pathological features of MOG antibody-positive cerebral cortical encephalitis as a new spectrum associated with MOG antibodies: a case report","volume":"392","author":"Ikeda","year":"2018","journal-title":"J Neurol Sci"},{"key":"B59","doi-asserted-by":"publisher","first-page":"100338","DOI":"10.1016\/j.ebr.2019.100338","article-title":"Overlapping demyelinating syndrome and anti-n-methyl-d-aspartate receptor encephalitis with seizures","volume":"12","author":"Taraschenko","year":"2019","journal-title":"Epilepsy Behav Rep"},{"key":"B60","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.msard.2018.10.012","article-title":"Aphasic status epilepticus preceding tumefactive left hemisphere lesion in anti-MOG antibody associated disease","volume":"27","author":"Katsuse","year":"2019","journal-title":"Mult Sclero Relat Disorde"},{"key":"B61","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1111\/dmcn.14032","article-title":"Isolated seizures during the first episode of relapsing myelin oligodendrocyte glycoprotein antibody-associated demyelination in children","volume":"61","author":"Ramanathan","year":"2019","journal-title":"Dev Med Child Neurol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/ana.24117","article-title":"Overlapping demyelinating syndromes and anti-N-Methyl-D-aspartate receptor encephalitis: anti-NMDAR encephalitis","volume":"75","author":"Titulaer","year":"2014","journal-title":"Ann Neurol"},{"key":"B63","unstructured":"Care report: seizure, fever, hallucinations & vision loss, a circuitous route to dual diagnoses\n            CarrollE\n            WallachA\n            KurzweilA\n            FruchtS\n            BerkT\n            BoffaM\n          Pract Neurol.2019"},{"key":"B64","doi-asserted-by":"publisher","first-page":"e2302","DOI":"10.1212\/WNL.0000000000009239","article-title":"Clinical significance of anti-NMDAR concurrent with glial or neuronal surface antibodies","volume":"94","author":"Martinez-Hernandez","year":"2020","journal-title":"Neurology"},{"key":"B65","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.msard.2019.01.053","article-title":"MOG antibody disease manifesting as progressive cognitive deterioration and behavioral changes with primary central nervous system vasculitis","volume":"30","author":"Baba","year":"2019","journal-title":"Mult Sclero Relat Disorde"},{"key":"B66","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1212\/NXI.0000000000000538","article-title":"Anti-MOG encephalitis mimicking small vessel CNS vasculitis","volume":"6","author":"Patterson","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B67","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s00401-012-0973-9","article-title":"Primary central nervous system vasculitis: pathology and mechanisms","volume":"123","author":"Giannini","year":"2012","journal-title":"Acta Neuropathol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s12974-016-0719-z","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: brainstem involvement - frequency, presentation and outcome","volume":"13","author":"Jarius","year":"2016","journal-title":"J Neuroinflamm"},{"key":"B69","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1093\/brain\/aww350","article-title":"Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis","volume":"140","author":"Jurynczyk","year":"2017","journal-title":"Brain"},{"key":"B70","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"B71","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1111\/ene.13483","article-title":"CLIPPERS mimickers: relapsing brainstem encephalitis associated with anti-MOG antibodies","volume":"25","author":"Berzero","year":"2018","journal-title":"Eur J Neurol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1212\/WNL.0000000000001370","article-title":"Anti-MOG antibodies with longitudinally extensive transverse myelitis preceded by CLIPPERS","volume":"84","author":"Symmonds","year":"2015","journal-title":"Neurology"},{"key":"B73","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1212\/01.wnl.0000472753.44905.98","article-title":"ANti-MOG antibodies with longitudinally extensive transverse myelitis preceded by CLIPPERS","volume":"85","author":"Taieb","year":"2015","journal-title":"Neurology"},{"key":"B74","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1001\/jamaneurol.2019.3656","article-title":"Coexistence of myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies in adult and pediatric patients","volume":"77","author":"Kunchok","year":"2019","journal-title":"JAMA Neurol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"e1867","DOI":"10.1212\/WNL.0000000000008479","article-title":"Relevance of antibodies to myelin oligodendrocyte glycoprotein in CSF of seronegative cases","volume":"93","author":"Mariotto","year":"2019","journal-title":"Neurology"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2020.00960\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T04:19:44Z","timestamp":1599625184000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2020.00960\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,9]]},"references-count":75,"alternative-id":["10.3389\/fneur.2020.00960"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2020.00960","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,9]]},"article-number":"960"}}